HOME >> MEDICINE >> NEWS
Evanston Northwestern Healthcare first to use latest robotic surgical system

Evanston Northwestern Healthcare (ENH) today announced that Evanston Hospital will be the first facility in Illinois to perform surgery using Intuitive Surgical's da Vinci S Surgical System.

The da Vinci S Surgical System is an addition to Intuitive Surgical's da Vinci product line. da Vinci is a state-of-the-art robotic-system designed to expand the surgeon's capabilities, providing patients with a minimally invasive option for many complex procedures for the very first time.

The da Vinci System allows surgeons to perform complex procedures including prostate, heart and gynecological surgery -- using dime-sized incisions. For most patients, this minimally invasive approach results in significantly less pain, less blood loss, shorter recovery periods and a quicker return to normal daily activities.

The da Vinci S is Evanston Northwestern Healthcare's first da Vinci Surgical System as well as the first da Vinci S model in clinical service in Illinois. At Evanston Hospital, prostate cancer patients will be among the first to undergo da Vinci Surgery with William K. Johnston III, MD, Director of Laparoscopy and Minimally Invasive Urology and Assistant Professor at Northwestern University's Feinberg School of Medicine. Dr. Johnston was formally trained in laparoscopic and robotic surgery at the University of Michigan.

"While patients will experience shorter hospital stays with less post operative pain and they typically can return to their daily routine in one week rather than six, I am equally excited about the opportunity to improve surgical outcomes with improved vision and dexterity afforded by the robotic arms and fiber optic 3-D imaging in our new S-version of the da Vinci," said Dr. Johnston.

By enhancing surgical capabilities, da Vinci Surgery is helping to improve clinical outcomes and redefine standards of care. Along with offering the many potential benefits of minimally invasive sur
'"/>

Contact: Amy Ferguson
AFerguson@enh.org
847-570-3146
Evanston Northwestern Healthcare
22-Mar-2006


Page: 1 2 3

Related medicine news :

1. Northwestern chemists develop new method for synthesizing anti-cancer flavonoids
2. $15M Northwestern grant funds heart research
3. Northwestern surgeon invents teaching technology for scary patient exams
4. Northwestern Memorial earns magnet status for nursing excellence
5. Heart transplant program at Northwestern Memorial Hospital celebrates anniversary
6. Northwestern researchers launch Avastin trial for pancreatic tumors
7. Northwestern Memorial Hospital named Bariatric Surgery Society Center of Excellence
8. Northwestern receives major award for nanotechnology cancer center
9. Northwestern Memorial named one of 100 Best Places for Working Mothers
10. Northwestern Memorial named among 100 Most Wired Hospitals for sixth consecutive year
11. Northwestern Memorial Hospital installs 64-Slice CT scanner, now available for clinical use

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: